SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

@MHRA: regulators could track #drug reactions via Twitter

Tweet tweet... Patients share three times more adverse events on Twitter than official channels. (Picture: Jennie/Flickr)

The UK Medicines and Healthcare products Regulatory Agency (MHRA) says Twitter, Facebook and smartphone apps could soon be used to gather adverse drug reactions (ADRs).

Related news

News in brief

High importation costs and country-to-country differences in national healthcare systems mean drugmakers will continue to vary the cost of products in Africa according to an industry analyst.

Industry groups BIO (Biotechnology Industry Association) and GPhA (Generic Pharmaceutical Association) are calling for outsourcing facilities to be held to the same standards as other, larger manufacturers.

A new list of biopharmaceuticals published by the US FDA provides limited information with only the entries for Neupogen, Perjecta and Granix including expiry dates.

Molecular Profiles has expanded its capsule-filling services from solids to liquids with investment in equipment at its UK site.

The Natoli Engineering Company has opened an pharmaceutical research institute to look for answers to enduring formulation problems in solid oral dosage.

Global Industry News

Marken’s Brazilian depot to receive first shipment this month from Outsourcing-Pharma.com

Marken expects the first batch of trial supplies to reach its new depot in Sao Paulo, Brazil later this month.

Update

Covance clinical issues normalize from Outsourcing-Pharma.com

Higher than normal cancellations for Covance’s clinical business have persisted now for a couple of quarters, though that downturn has since normalized and CEO Joe Herring believes the company was just in a short-lived rut.

Medidata, Icon partner on electronic patient-reported outcomes from Outsourcing-Pharma.com

Cloud-based solution provider Medidata and CRO Icon have launched a joint initiative to bring new efficiency to the administration of electronic patient-reported outcomes (ePROs) in clinical trials. 

PRA Health Sciences evaluates IPO option again with SEC filing from Outsourcing-Pharma.com

A little more than a year after it was acquired by private equity company KKR (Kohlberg Kravis Roberts & Co.) for $1.4bn , newly rebranded PRA Health Sciences is looking to go public with an IPO.

WCG looks to galvanize northeast clients with New England IRB acquisition from Outsourcing-Pharma.com

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for clinical research, announced today it has acquired New England Independent Review Board (IRB). 

Web tool to match sponsors to trial sites in low-income countries from Outsourcing-Pharma.com

A free online tool could help trial sponsors with the “incredibly difficult” task of finding study sites in developing regions.

Spotlight

SCM's woes part of UK-wide aseptic slowdown, says ex-owner

SCM's woes part of UK-wide aseptic slowdown, says ex-owner

GMP failures at an aseptic plant owned by SCM Pharma are part of a wider industry trend...

Boehringer aims to cut German costs 15% as H1 sales fall

Boehringer Ingelheim aims to cut German costs 15% as revenues drop

German jobs are safe despite a programme that will cut the cost of operations by 15%, Boehringer...

WHO: Data from use of unapproved Ebola drugs should be shared

WHO: Data from use of unapproved Ebola drugs should be shared

Efficacy and safety data from use of unapproved Ebola virus treatments should be shared according to an...

THC may reduce tumor size? mouse study investigates

THC may reduce tumor size? mouse study investigates

A previously unknown signaling platform may be responsible for the success of the main psychoactive ingredient in...

India’s CDSCO outlines procedures for state manufacturer inspections

India’s CDSCO outlines procedures for state inspections of manufacturers

In order to ensure uniformity on the state and federal levels, India’s CDSCO (Central Drugs Standard Control...

Roche re-enters RNAi space with $250m Santaris acquisition

Roche re-enters gene silencing space with $250m LNA acquisition

Roche has renewed its interest in gene silencing drugs, paying $250m (€187m) for Santaris Pharma including its...

Key Industry Events

 

Access all events listing

Our events, Events from partners...